Combination of mTOR inhibition and paclitaxel as a personalised strategy in the context of MYC-amplified high-grade serous ovarian cancer
- Authors:
- FC Martins, D-L Couturier, I de Santiago, M Vias, D Sanders, A Piskorz, J Hall, M Jimenez-Linan, K Hosking, R Crawford, J Brenton
- Journal:
- ANNALS OF ONCOLOGY
- Citation info:
- Vol. 30
- Publication date:
- 1st Aug 2019
- Full text
- DOI